## APTV: Aptiv PLC - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -1.6% below STRENGTH zone (3.0-6.0%); PEG 1.07 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($72.25)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Wells Fargo Lowers Price Target for Aptiv (APTV), Maintains Over**
- Source: GuruFocus | 20251209T190454 | Somewhat-Bullish | Relevance: 98%
-  Wells Fargo has maintained its "Overweight" rating for Aptiv (APTV) but slightly lowered its price target from $100.00 to $99.00. This adjustment still reflects a positive outlook on Aptiv's future performance. Other analysts have also recently made positive adjustments to their ratings and price targets for Aptiv.

**2. Aptiv (APTV) Rating and Price Target Raised by Morgan Stanley**
- Source: GuruFocus | 20251208T175451 | Bullish | Relevance: 98%
-  Morgan Stanley analyst Adam Jonas upgraded Aptiv (APTV) from 'Underweight' to 'Equal-Weight' and significantly raised the price target from $60.00 to $84.00, a 40% increase. This adjustment reflects a more positive outlook on Aptiv's future performance. Several other analysts have also adjusted their ratings and price targets for Aptiv in recent months, with the average analyst target price indicating a potential upside of 24.49% from its current price.

**3. Should WisdomTree U.S. MidCap ETF (EZM) Be on Your Investing Radar?**
- Source: Yahoo Finance | 20251208T110926 | Neutral | Relevance: 72%
-  The WisdomTree U.S. MidCap ETF (EZM) offers investors exposure to the Mid Cap Value segment of the US equity market with assets over $819.27 million. With an expense ratio of 0.38% and a Zacks ETF Rank of 3 (Hold), EZM provides a diversified, medium-risk option for investors seeking this market exposure. The fund primarily invests in the Energy, Industrials, and Materials sectors, with Dreyfus Trsy Oblig Cash Mgmt Cl Ins and Us Dollar as its top holdings.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Wells Fargo | $99 | $100 | -1% |
| 2025-12-08 | Morgan Stanley | $84 | $60 | +40% |
| 2025-11-19 | RBC Capital | $101 | $101 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Wells Fargo | main | Overweight |
| 2025-12-08 | Morgan Stanley | up | Equal-Weight |
| 2025-11-19 | RBC Capital | reit | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($4.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-1.0%)
- Blackrock Inc.: 8.0% (+2.2%)
- Massachusetts Financ: 4.3% (-15.7%)
- State Street Corpora: 4.1% (-1.1%)
- Barrow, Hanley Mewhi: 3.2% (-6.9%)

### Key Risks

1. Insider selling cluster: $4.4M in recent transactions.
2. Near-term weakness: 6.0% below SMA50 despite long-term uptrend.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.07 suggests fair value with growth premium. Insider selling cluster ($4.4M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.6B |
| Beta | 1.52 |
| 52W Range | $47.19 - $88.80 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.07 |
| Forward P/E | 9.1 |
| Current P/E | 9.9 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.3% to -1.6% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.5pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). RSI neutral at 44.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.55% (CS: 42) | Neutral |
| RSI_14 | 43.8 | Neutral |
| MACD Histogram | 0.30 | Bullish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 0.940x | Below |
| vs SMA200 | 1.073x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $76.35
- **Stop Loss:** $72.25 (5.4% risk)
- **Target:** $80.45 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 121
- **Position Value:** $9,238.35
- **Portfolio %:** 9.24%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-05 (Est: $1.80)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.83 | $2.17 | +18.8% |
| 2025Q2 | $1.83 | $2.12 | +15.8% |
| 2025Q1 | $1.53 | $1.69 | +10.1% |
| 2024Q4 | $1.65 | $1.75 | +6.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*